Picture of 3SBio logo

1530 3SBio Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapContrarian

Annual income statement for 3SBio, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
R2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSPRESSPRESS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue5,3185,5886,3826,8667,816
Cost of Revenue
Gross Profit4,3934,5255,2765,6726,642
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses3,9754,4974,4104,4495,595
Operating Profit1,3441,0911,9722,4172,221
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes1,2239791,8692,2801,978
Provision for Income Taxes
Net Income After Taxes9807711,6281,9091,586
Minority Interest
Net Income Before Extraordinary Items
Net Income9748361,6511,9161,549
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income9748361,6511,9691,525
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.3850.3530.6050.8210.609
Dividends per Share